OWL-LABS
4.6.2024 15:31:27 CEST | Business Wire | Press release
Owl Labs, the first company to build AI-powered, 360-degree video conferencing solutions, today launched its next-generation flagship product, the Meeting Owl 4+. It is Owl Labs’ newest all-in-one, 360-degree camera, speaker, and mic device with 4K Ultra HD video for crystal clear video that’s sharper than ever. The new Meeting Owl is powered by the latest Owl Intelligence System (OIS) Software which now allows for wirelessly pairing more devices, so organisations can customise their spaces to meet their evolving needs.
Over 200,000 organisations across nearly 50 countries, from small businesses to 89 companies on the Fortune 100 list to educational institutions, have used Owl Labs products to power millions of hybrid experiences. Owl devices use robotics and proprietary, patented AI-powered software to automatically switch between cameras to capture the best view of in-room attendees, enabling natural, face-to-face conversations that transcend physical distance. With the introduction of the Meeting Owl 4+, Owl Labs now offers enhanced capabilities to more audiences, from small and medium-sized businesses (SMBs) to larger enterprises. In addition to pairing with more devices to cover larger spaces, the Meeting Owl 4+ has several other enterprise-friendly features, including easier fleet management for IT teams and customisable lighting and sound options upon startup.
With the latest AI-powered OIS software, the Meeting Owl 4+ pairs with Owl Labs’ customisable connected device system to capture all angles of the discussion. Owl Labs products can connect with others in over 25 different setup configurations, with both centre-of-room and front-and-centre options. For example, a company can wirelessly connect two Meeting Owls for greater coverage, or a Meeting Owl and an Owl BarTM to ensure all angles are covered, creating a full-room solution. The software is developed in the U.S. by an experienced team of engineers who are continually iterating to make Owl products smarter over time. All software adheres to industry-standard security protocols and Owl devices connect via a private, dedicated wireless network.
This launch is the latest advancement in Owl Labs’ mission to make hybrid meetings more inclusive and collaborative by leveling the playing field between remote and in-room participants. Hundreds of thousands of workplaces have moved beyond traditional conference room setups with equipment permanently mounted to walls and transitioned to user-friendly, plug-and-play Owl products with the flexibility, portability, and affordability that modern distributed offices need. Any type of meeting, in any size room, is covered with Owl Labs’ tailored technology, from sit-down roundtables to stand-up presentations to brainstorms on whiteboards. As companies grow, their video conferencing infrastructure adapts and expands with them. However, a vast market opportunity remains as Owl Labs’ State of Hybrid Work report found only 37% of employers upgraded their video meeting technology in the past year.
“Non-verbal communication is crucial in the workplace for collaboration and rapport, and studies have even shown that non-verbal communication is at least as important as verbal discussion, if not more,” said Frank Weishaupt, CEO of Owl Labs. “As the hybrid workplace has evolved beyond meetings where everyone is in the same room, we need to do away with outdated video technology that doesn't allow remote attendees to clearly see and hear during meetings. Meanwhile, today’s enterprise businesses are evolving their offices and processes faster than ever to keep up with the pace of economic and AI-driven transformation. At Owl Labs, we’re building easy-to-use meeting technology that’s as nimble as they are, from small businesses to the largest enterprises.”
The flexible, plug-and-play Meeting Owl 4+ is enterprise-ready and takes less than six minutes to set up. Features include:
- Upgraded video quality: The 64-megapixel camera and sensor streams 4K Ultra HD video within a 10-foot radius.
- Wide-range audio: Powerful, 360-degree speakers and smart mics have an 18-foot pickup radius. Extend the audio range even farther with the new matching, charcoal Expansion Mic.
- Easy enterprise fleet management: IT administrators can seamlessly manage their fleet of Owl Labs devices from The Nest management tool, including bulk registration, default settings, and more.
The upgraded OIS software includes:
- Silent Switching: When devices are paired, the technology detects where people are facing even when they’re not speaking, then seamlessly switches to the correct camera with the best view.
- Quick and easy setup: Pair devices quickly, effortlessly and efficiently.
- Platform-agnostic: Compatible with Microsoft Teams, Zoom, Google Meet, Slack, and other video conferencing platforms.
- Improved Front + Centre Experience: Front + Centre experience upgrades introduce more accurate intelligent camera switching whether a participant is actively speaking or silently contributing to ensure the best angle is captured at all times.
The new Meeting Owl 4+ is launching in the United States, Canada and Europe. Customers in the UK can now purchase it for £1,999 / €2,199 (including VAT) through OwlLabs.com, Amazon, or third-party resellers and distribution partners. Find your local reseller or contact sales@owllabs.com.
To see video of the Meeting Owl 4+ in action, purchase other Owl Labs products or ensure your devices have the latest OIS software, visit owllabs.co.uk.
About Owl Labs:
Owl Labs is the first company to build AI-powered, 360-degree video conferencing solutions for hybrid organisations. Its connected device system and Owl Intelligence System™ software make meetings more inclusive and collaborative by leveling the playing field between remote and in-room participants. The Meeting Owl® 4+ is the latest generation of the first WiFi-enabled, 360-degree camera, microphone and speaker that automatically zooms in on whoever’s speaking. Owl Labs has raised £36.8 million in funding and is based in Boston, with remote and hybrid employees all over the world. To learn more and explore the company’s research on the State of Hybrid Work, visit OwlLabs.co.uk.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240531450854/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
